Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://news.bmn.com/magazine/conferencereport?uid=CNFR.2003-PAG-XI-1-s6

 
Journal
Collection
Reviews Research
Update
Research
Tools
News &
Features
Books &
Labware
Science
Jobs
news.bmn.com Latest
Updates
Today's
News
Magazine Conference
Reporter
Commentary Journal
Scan
Special
Report
My E-mail
Alerts
Section
Search
  My BMN My BMN Exit Exit  
  Send Feedback to BMN Feedback Help System Help  


 

About this Section
Conference Reporter
BioMedNet's conference-based news service provides online reports from major scientific conferences. Online the day after scientists have presented their results, stories are written by our team of expert science journalists.

 
orange-cells

 
Did you know?
Conference Reporter is covering 12 conferences this year. View full list.

 
Email Alerts
You can sign up to have each days conference headlines delivered daily to your inbox during meetings. Sign Up.

 
Access To This Section
All articles in this section are FREE to registered BioMedNet members.


 

 


 
 

With the wrong enzyme, broccoli could be harmful to your health
11 January 2003
by Rabiya Tuma
If you hated broccoli, cabbage and Brussels sprouts as a kid, take heart, most plant-eating pests agree with you. But some pests have developed ways to get around the bitter-tasting toxins these plants manufacture for their defense and, now, one researcher can show exactly how one insect does it.



 

Plants have evolved multiple mechanisms to defend themselves against herbivorous insects. One technique they use is to manufacture and store distasteful or toxic compounds in their leaves so that caterpillars and other insects find that one bite is more than enough, says Dan Kliebenstein, from the University of California at Davis. Brassicas, which include broccoli, cabbage, Brussels sprouts and Arabidopsis thaliana, make compounds called glucosinolates for this purpose. "All the flavors you hated to eat as a child are glucosinolates," said Kliebenstein.

For humans, a slightly bitter taste is the worst of the glucosinolates - and, in fact, these compounds are the ones thought to have cancer fighting activity - but for small insects who want to make their whole meal on raw Arabidopsis, the problem can be much more significant. The plant makes both a family of compounds called glucosinolates and an enzyme called myrosinase. A healthy leaf stores the two components in separate compartments. However, when a caterpillar or other herbivorous insect takes a bite out of the leaf, cell walls and compartments are broken down, allowing the enzyme and glucosinolates to come into contact, at which time the enzyme converts the bitter-tasting compound into a toxic one.

Of course, over evolution some pests have found ways to get around the problem. When Kliebenstein tested a pest who feeds on a wide range of plants and is, therefore, categorized as a generalist, he found that the caterpillars were sensitive to the gluocsinolates. However, when he tested a specialist pest that has evolved to feed almost exclusively on brassicas, he found that, across the board, they were resistant to the toxic effects of the glucosinolates.

So just how does a specialist pest, like Plutella xylostella, avoid the toxin? To get an idea of how the caterpillar was metabolizing the glucosinolates, Kliebenstein and his colleagues collected the insect's feces, dissolved it in water and analyzed it with high pressure liquid chromatography (HPLC). Interestingly, the team found that the glucosinolates were passing through the animal relatively unchanged, as if the plant didn't even have the myrosinase enzyme at all.

The researchers subsequently found that one of the major proteins in the caterpillar's spit is an enzyme that removes a sulfur group from the glucosinolates. Without this sulfur group, the plant's own enzyme, myrosinase, doesn't recognize the glucosinolate and therefore can't convert it to a toxic compound, leaving the pest free to chew away at the now defenseless plant.

"This is a nice bit of work," said Neal Gutterson, who works on functional genomics in Arabidopsis at Mendel Biotechnology, Inc. in Hayward, California, "especially the part about how the specialist detoxifies the compound."

Joseph Anderson, from the USDA/ARS Crop Production and Pest Control Research Unit at Purdue University in West Lafayette, Indiana, told BioMedNet News that Kliebenstein's work on glucosinolates in Arabidopsis is "quite applicable to other plant systems." Because many plants use secondary metabolites, like glucosinolates, what scientists learn in this model system will be generally transferable to other plants - and their pests.



Bullet All articles from BioMedNet's Conference Reporter are free to BioMedNet members

Bullet See more
Conference Reporter stories

Bullet Please send us your feedback on this magazine
 

 
BioMedNet Magazine
15th - 28th January 2003
home icon Magazine Home
email icon Email to a Friend
full article icon Printer Ready Version

 
Further Reading
Direct and ecological costs of resistance to herbivory
[Trends in Ecology and Evolution]
S Strauss and J Rudgers
Trends in Ecology and Evolution, 2002, 17:6:278-285

 
Producing proteins in transgenic plants and animals
[Current Opinion in Biotechnology]
J Larrick and D Thomas
Current Opinion in Biotechnology, 2001, 12:4:411-418

 
Genetics and biochemistry of secondary metabolites in plants: an evolutionary perspective
[Trends in Plant Science]
E Pichersky and D Gang
Trends in Plant Science, 2000, 5:10:439-445

 


 



 
 


BioMedNet
Home
News &
Features
My BMN
 
Help System
 
Send Feedback to BMN
 
Information for Advertisers © Elsevier Limited 2003

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.